Concord Biotech Ltd.
543960
ISIN INE338H01029 / Valor 128746036
Concord Biotech Ltd.
UMushroom community rating:
About company
Concord Biotech Limited is an Ahmedabad-based biopharmaceutical company, founded in 2000 by Sudhir Vaid (Chairman & MD), a former director at Ranbaxy Laboratories. Led by CEO Ankur Vaid, the company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide. It was the first company in India and the second in the world to develop tacrolimus (an anti-immunosuppressant). Products span immunosuppressant, oncology, antifungal, antibacterial and anthelmintic therapy segments. Manufacturing facilities are at Dholka (near Ahmedabad; USFDA-approved) and Limbasi (Kheda district). In April 2026, the company acquired 100% of Celliimune Biotech for ₹66 lakh. Revenue ₹1,016 crore FY24; operating profit ₹466 crore FY24; net profit ₹308 crore FY24; 1,180 employees. Market capitalisation approximately ₹12,579 crore. Listed on both BSE and NSE (CONCORDBIO).
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1198 M
Market cap (USD)
8,961
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
